MiRNA-based therapy for pulmonary hypertension: MiRNA-325-3p suppresses pulmonary hypertension via down regulation of its target gene, 17/March/2015, 17.56

Natural product-based therapy for pulmonary arterial hypertension: Scopoletin, found in chicory, in Artemisia scoparia, in Stinging Nettle, and in the passion flower, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 17/May/2015, 15.33
May 17, 2015
A known anti-cancer drug of an Unknown anti-hypertensive function: Campothecin (CPT) stifles pulmonary hypertension via up regulation of its target gene, 17/March/2015, 22.49
May 17, 2015
Show all

A recent study from the from the Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States of America shows that “High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4. This study was published in the 8 Feb’13  issue of the Journal “Molecular Medicine”  by Drs. Bauer PMBauer EM and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: MiRNA-based therapy for pulmonary hypertension: MiRNA-325-3p  suppresses pulmonary hypertension via down regulation of its target gene. This study suggests, for the first time, that MiRNA-325-3p, by decreasing the expression of its target gene, may: (1) decrease Right ventricular systolic pressure, and (2) inhibit thickening of the pulmonary artery wall. Together, pharmacological formulations encompassing “MiRNA-325-3p  or its activators may be used to treat patients suffering from pulmonary hypertension.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  MiRNA-based therapy for pulmonary hypertension: MiRNA-325-3p suppresses pulmonary hypertension via down regulation of its target gene, 17/March/2015,  17.56,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How MiRNA-325-3p  stifles pulmonary hypertension

Comments are closed.